Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer: A Network Meta-Analysis of Randomized Clinical Trials

Objective: This network meta-analysis will provide a complete toxicity profile, toxicity profile, and safety ranking of immune checkpoint inhibitors (ICIs) for treatment of advanced non-small cell lung cancer (NSCLC). Methods: We found 12 phase II or III randomized clinical trials (RCTs) including 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weidong, Gu, Jingjing, Bian, Chunming, Huang, Guanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574003/
https://www.ncbi.nlm.nih.gov/pubmed/34759817
http://dx.doi.org/10.3389/fphar.2021.686876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574003/
https://www.ncbi.nlm.nih.gov/pubmed/34759817
http://dx.doi.org/10.3389/fphar.2021.686876

Ejemplares similares